KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Accumulated Expenses (2020 - 2026)

Gilead Sciences filings provide 11 years of Other Accumulated Expenses readings, the most recent being $4.0 billion for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 27.65% to $4.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 billion, a 27.65% decrease, with the full-year FY2025 number at $4.0 billion, down 27.65% from a year prior.
  • Other Accumulated Expenses hit $4.0 billion in Q4 2025 for Gilead Sciences, up from $3.8 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.1 billion in Q4 2021 to a low of $3.6 billion in Q2 2025.
  • Median Other Accumulated Expenses over the past 5 years was $4.6 billion (2022), compared with a mean of $4.8 billion.
  • Biggest five-year swings in Other Accumulated Expenses: soared 168.69% in 2021 and later decreased 27.65% in 2025.
  • Gilead Sciences' Other Accumulated Expenses stood at $6.1 billion in 2021, then fell by 25.47% to $4.6 billion in 2022, then increased by 12.01% to $5.1 billion in 2023, then grew by 6.51% to $5.5 billion in 2024, then dropped by 27.65% to $4.0 billion in 2025.
  • The last three reported values for Other Accumulated Expenses were $4.0 billion (Q4 2025), $3.8 billion (Q3 2025), and $3.6 billion (Q2 2025) per Business Quant data.